AC
Adage Capital Management, L.P. disclosed a 5.8% stake in TRAX
Adage Capital Management, L.P. reported owning 5.8% of First Tracks Biotherapeutics, Inc. (TRAX) (2,077,179 shares) in a Schedule 13G filed Nov 12, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 12, 2026
- Source
- Schedule 13G